Skip to main content
MorphoSys AG (MOR)
NASDAQ: MOR · IEX Real-Time Price · USD
18.39
+0.03 (0.16%)
May 31, 2024, 4:30 PM EDT - Market closed

MorphoSys AG Revenue

In the year 2023, MorphoSys AG had annual revenue of $264.75M, a decrease of -10.56%.

Revenue (ttm)
$264.75M
Revenue Growth
+6.07%
P/S Ratio
10.46
Revenue / Employee
$505,255
Employees
524
Market Cap
2.77B USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023264.75M-31.28M-10.56%
Dec 31, 2022296.03M91.92M45.04%
Dec 31, 2021204.10M-195.53M-48.93%
Dec 31, 2020399.63M319.01M395.67%
Dec 31, 201980.62M-7.24M-8.24%
Dec 31, 201887.86M7.71M9.62%
Dec 31, 201780.15M27.80M53.11%
Dec 31, 201652.35M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Neogen 929.24M
PTC Therapeutics 927.56M
Azenta 651.76M
iRhythm Technologies 513.17M
Certara 360.69M
Arcellx 131.66M
Arrowhead Pharmaceuticals 35.47M
IDEAYA Biosciences 15.50M
Revenue Rankings

MOR News

More News